“So Monday’s PR should be trial ended?” I
Post# of 154227

IMO, no PR on that because the PR last Thursday afternoon announced full enrollment of the trial and that data would available after the last patient completed 2 weeks of treatment.
You think this will move the market ?
The only PR that moves the market in terms of COVID19 is either good data or a licensing deal.

